colesevelam HCl + placebo
Phase 2/3Completed 0 views this week 0 watching💤 Quiet
Interest: 38/100
38
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes
Conditions
Type 2 Diabetes
Trial Timeline
Sep 1, 2009 → Sep 1, 2011
NCT ID
NCT00993824About colesevelam HCl + placebo
colesevelam HCl + placebo is a phase 2/3 stage product being developed by Daiichi Sankyo for Type 2 Diabetes. The current trial status is completed. This product is registered under clinical trial identifier NCT00993824. Target conditions include Type 2 Diabetes.
What happened to similar drugs?
20 of 20 similar drugs in Type 2 Diabetes were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
15
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00993824 | Phase 2/3 | Completed |
| NCT00938405 | Pre-clinical | Completed |
| NCT00145574 | Approved | Completed |
Competing Products
20 competing products in Type 2 Diabetes